Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.
-
Paragraph 0732; 0735; 0736
(2018/06/04)
Glutamate receptor antagonists
The present invention is a compound of formula wherein X is an ethynediyl group, R1, R2and R3are as defined in the specification.
-
(2008/06/13)
More Articles about upstream products of 335254-97-2